OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Registration to our newsletter is FREE, Join today by entering your email below!

Tag Archives: pixantrone

Is Cell Therapeutics, Inc. (NASDAQ: CTIC) Any Closer to FDA Approval for non-Hodgkin’s Lymphoma Drug Pixantrone?

Posted on December 1, 2011 by Editor

The road to FDA approval for Cell Therapeutics, Inc. (NASDAQ: CTIC) has been one littered with speed bumps and potholes yet the biotechnology company now sits just a few months away from potentially clearing the final hurdle and advancing their … Continue reading →

Posted in Articles, NASDAQ, Penny Stocks | Tagged , , , , , , , , | Leave a comment

Cell Therapeutics Inc. (NASDAQ: CTIC) Failing to Inspire Investors, Disappointing Shareholders, and Confusing the FDA

Posted on March 23, 2011 by Editor

It has been more than a year since shares in Cell Therapeutics Inc. (NASDAQ: CTIC) tanked following a unanimous 9-0 vote by the FDA rejecting the biotechnology company’s drug pixantrone for the treatment of non-Hodgkin’s lymphoma. Since that time CTIC … Continue reading →

Posted in Articles, NASDAQ, Small Cap | Tagged , , , , , , , , , , | Leave a comment